APO RESEARCH · REPORT
Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane
Selected research
Market Structure
Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane include Biomatlante, Biomedical Tissues, Bio-tech, Botiss, Dentsply Sirona, Geistlich Pharma, Genoss, Keystone Dental and Lynch Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market size, projected growth trends, production technologies, key applications, and end-use industries.
Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Segment by Company
Biomatlante
Biomedical Tissues
Bio-tech
Botiss
Dentsply Sirona
Geistlich Pharma
Genoss
Keystone Dental
Lynch Biologics
MegaGen Impant
Neoss Limited
Nobel Biocare Services/Danaher Corporation
OraPharma
Salvin Dental Specialties,Inc
Sunstar
Yantai Zhenghai Bio-tech
Zimmer Biomet
Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Segment by Type
Absorbable Membrane
Non-resorbable Membrane
Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Segment by Application
Dental
Hospital
Clinic
Other
Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Absorbable Membrane
- Non-resorbable Membrane
Applications
- Dental
- Hospital
- Clinic
- Other
Companies covered
- Biomatlante
- Biomedical Tissues
- Bio-tech
- Botiss
- Dentsply Sirona
- Geistlich Pharma
- Genoss
- Keystone Dental
- Lynch Biologics
- MegaGen Impant
- Neoss Limited
- Nobel Biocare Services/Danaher Corporation
- OraPharma
- Salvin Dental Specialties,Inc
- Sunstar
- Yantai Zhenghai Bio-tech
- Zimmer Biomet
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Dynamics
- 2.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Trends
- 2.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Drivers
- 2.3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Opportunities and Challenges
- 2.4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Restraints
3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market by Manufacturers
- 3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Manufacturers (2021-2026)
- 3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Manufacturers (2021-2026)
- 3.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Manufacturers, Product Type & Application
- 3.7 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Players Market Share by Revenue in 2025
- 3.8.3 2025 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Tier 1, Tier 2, and Tier 3
4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market by Type
- 4.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Type Introduction
- 4.1.1 Absorbable Membrane
- 4.1.2 Non-resorbable Membrane
- 4.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Type
- 4.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Type (2021-2032)
- 4.2.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Type (2021-2032)
- 4.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type
- 4.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2021-2032)
- 4.3.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Market Share by Type (2021-2032)
5 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market by Application
- 5.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Application Introduction
- 5.1.1 Dental
- 5.1.2 Hospital
- 5.1.3 Clinic
- 5.1.4 Other
- 5.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Application
- 5.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Application (2021-2032)
- 5.2.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Application (2021-2032)
- 5.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application
- 5.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2021-2032)
- 5.3.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Market Share by Application (2021-2032)
6 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region
- 6.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region (2021-2032)
- 6.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region (2021-2026)
- 6.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region
- 7.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region
- 7.1.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2021-2026)
- 7.1.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2027-2032)
- 7.1.4 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue (2021-2032)
- 7.2.2 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue (2021-2032)
- 7.3.2 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue (2021-2032)
- 7.4.2 Asia-Pacific Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Biomatlante
- 8.1.1 Biomatlante Company Information
- 8.1.2 Biomatlante Business Overview
- 8.1.3 Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.1.5 Biomatlante Recent Developments
- 8.2 Biomedical Tissues
- 8.2.1 Biomedical Tissues Company Information
- 8.2.2 Biomedical Tissues Business Overview
- 8.2.3 Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.2.5 Biomedical Tissues Recent Developments
- 8.3 Bio-tech
- 8.3.1 Bio-tech Company Information
- 8.3.2 Bio-tech Business Overview
- 8.3.3 Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.3.5 Bio-tech Recent Developments
- 8.4 Botiss
- 8.4.1 Botiss Company Information
- 8.4.2 Botiss Business Overview
- 8.4.3 Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.4.5 Botiss Recent Developments
- 8.5 Dentsply Sirona
- 8.5.1 Dentsply Sirona Company Information
- 8.5.2 Dentsply Sirona Business Overview
- 8.5.3 Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.5.5 Dentsply Sirona Recent Developments
- 8.6 Geistlich Pharma
- 8.6.1 Geistlich Pharma Company Information
- 8.6.2 Geistlich Pharma Business Overview
- 8.6.3 Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.6.5 Geistlich Pharma Recent Developments
- 8.7 Genoss
- 8.7.1 Genoss Company Information
- 8.7.2 Genoss Business Overview
- 8.7.3 Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.7.5 Genoss Recent Developments
- 8.8 Keystone Dental
- 8.8.1 Keystone Dental Company Information
- 8.8.2 Keystone Dental Business Overview
- 8.8.3 Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.8.5 Keystone Dental Recent Developments
- 8.9 Lynch Biologics
- 8.9.1 Lynch Biologics Company Information
- 8.9.2 Lynch Biologics Business Overview
- 8.9.3 Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.9.5 Lynch Biologics Recent Developments
- 8.10 MegaGen Impant
- 8.10.1 MegaGen Impant Company Information
- 8.10.2 MegaGen Impant Business Overview
- 8.10.3 MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.10.5 MegaGen Impant Recent Developments
- 8.11 Neoss Limited
- 8.11.1 Neoss Limited Company Information
- 8.11.2 Neoss Limited Business Overview
- 8.11.3 Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.11.5 Neoss Limited Recent Developments
- 8.12 Nobel Biocare Services/Danaher Corporation
- 8.12.1 Nobel Biocare Services/Danaher Corporation Company Information
- 8.12.2 Nobel Biocare Services/Danaher Corporation Business Overview
- 8.12.3 Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.12.5 Nobel Biocare Services/Danaher Corporation Recent Developments
- 8.13 OraPharma
- 8.13.1 OraPharma Company Information
- 8.13.2 OraPharma Business Overview
- 8.13.3 OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.13.5 OraPharma Recent Developments
- 8.14 Salvin Dental Specialties,Inc
- 8.14.1 Salvin Dental Specialties,Inc Company Information
- 8.14.2 Salvin Dental Specialties,Inc Business Overview
- 8.14.3 Salvin Dental Specialties,Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Salvin Dental Specialties,Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.14.5 Salvin Dental Specialties,Inc Recent Developments
- 8.15 Sunstar
- 8.15.1 Sunstar Company Information
- 8.15.2 Sunstar Business Overview
- 8.15.3 Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.15.5 Sunstar Recent Developments
- 8.16 Yantai Zhenghai Bio-tech
- 8.16.1 Yantai Zhenghai Bio-tech Company Information
- 8.16.2 Yantai Zhenghai Bio-tech Business Overview
- 8.16.3 Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.16.5 Yantai Zhenghai Bio-tech Recent Developments
- 8.17 Zimmer Biomet
- 8.17.1 Zimmer Biomet Company Information
- 8.17.2 Zimmer Biomet Business Overview
- 8.17.3 Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
- 8.17.5 Zimmer Biomet Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Value Chain Analysis
- 9.1.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Production Mode & Process
- 9.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Distributors
- 9.2.3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst